Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Dec. 31, 2021			107,509,096
Balance at Dec. 31, 2021	$ 596,593	$ (22,147)	$ 108	$ 1,018,005	$ (30,794)	$ 6,083	$ (427,603)	$ 8,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	142,862			142,862
Common stock issued under employee stock plans (shares)			3,078,402
Common stock issued under employee stock plans	12,496		$ 3	12,493
Taxes paid related to net share settlement of equity awards	(31,076)			(31,076)
Repurchase of common stock (in shares)			(2,914,446)
Repurchase of common stock	(56,445)		$ (3)	(56,442)
Unrealized income (loss) on derivative instruments, net of tax	(15,363)					(15,363)
Unrealized income (loss) on available for sale securities, net of tax	(277)					(277)
Net loss	(124,518)						(124,518)
Balance (in shares) at Dec. 31, 2022			107,673,052
Balance at Dec. 31, 2022	502,125		$ 108	1,055,048		(9,557)	(543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	139,819			139,819
Common stock issued under employee stock plans (shares)			2,931,316
Common stock issued under employee stock plans	12,649		$ 2	12,647
Taxes paid related to net share settlement of equity awards	(21,415)			(21,415)
Repurchase of common stock (in shares)			(1,500,647)
Repurchase of common stock	(43,522)		$ (1)	(43,521)
Unrealized income (loss) on derivative instruments, net of tax	(1,040)					(1,040)
Unrealized income (loss) on available for sale securities, net of tax	1,948					1,948
Net loss	(100,916)						(100,916)
Balance (in shares) at Dec. 31, 2023			109,103,721
Balance at Dec. 31, 2023	489,648		$ 109	1,142,578		(8,649)	(644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	126,682			126,682
Common stock issued under employee stock plans (shares)			3,397,390
Common stock issued under employee stock plans	16,082		$ 3	16,079
Taxes paid related to net share settlement of equity awards	$ (38,295)			(38,295)
Repurchase of common stock (in shares)	0
Unrealized income (loss) on derivative instruments, net of tax	$ 15,423					15,423
Unrealized income (loss) on available for sale securities, net of tax	(4,098)					(4,098)
Common stock issued for debt conversion (in shares)			49,045
Common stock issued for debt conversion	1,501		$ 1	1,500
Purchase of capped calls related to Convertible senior notes	(55,522)			(55,522)
Net loss	(95,765)						(95,765)
Balance (in shares) at Dec. 31, 2024			112,550,156
Balance at Dec. 31, 2024	$ 455,656		$ 113	$ 1,193,022		$ 2,676	$ (740,155)